The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade-Reference-Cited by-同舟云学术

The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade

Published:2022-08-19 Issue:12 Volume:94 Page:5780-5789
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Geisen Ulf Martin¹^ORCID,Rose Ruben²,Neumann Franziska³,Ciripoi Maria¹,Vullriede Lena¹,Reid Hayley M.¹^ORCID,Berner Dennis Kristopher¹,Bertoglio Federico⁴,Hoff Paula⁵,Hust Michael⁴,Longardt Ann Carolin⁶,Lorentz Thomas³,Martini Gabriela Rios⁷⁸,Saggau Carina⁷,Schirmer Jan Henrik¹,Schubert Maren⁴,Sümbül Melike⁸,Tran Florian⁹¹⁰,Voß Mathias²,Zeuner Rainald¹,Morrison Peter J.⁸,Bacher Petra⁷⁹,Fickenscher Helmut²,Gerdes Sascha⁸,Peipp Matthias¹¹,Schreiber Stefan⁹¹⁰,Krumbholz Andi²³^ORCID,Hoyer Bimba Franziska¹

Affiliation:

1. Medical Department I, Rheumatology and Clinical Immunology University Medical Center Schleswig‐Holstein Campus Kiel Kiel Germany

2. Institute for Infection Medicine, Christian‐Albrecht University of Kiel and University Medical Center Schleswig‐Holstein Kiel Germany

3. Labor Dr. Krause und Kollegen MVZ GmbH Kiel Germany

4. Department of Biotechnology Institute of Biochemistry, Biotechnology, and Bioinformatics, Technische Universität Braunschweig Braunschweig Germany

5. Department of Rheumatology, Endokrinologikum‐Gruppe Berlin Germany

6. Department of Pediatrics University Medical Center Schleswig‐Holstein Kiel Germany

7. Institute of Immunology University Medical Center Schleswig‐Holstein Kiel Germany

8. Department for Dermatology University Medical Center Schleswig‐Holstein Kiel Germany

9. Institute of Clinical Molecular Biology Christian‐Albrecht University of Kiel Kiel Germany

10. Department for Internal Medicine I University Medical Center Schleswig‐Holstein Kiel

11. Department of Internal Medicine II, Division of Antibody‐Based Immunotherapy University Medical Center Schleswig‐Holstein Kiel Germany

Funder

Deutsche Forschungsgemeinschaft

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28063

Reference28 articles.

1. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

2. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

3. Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies

4. Reduced antibody activity against SARS‐CoV‐2 B.1.617.2 delta virus in serum of mRNA‐vaccinated individuals receiving tumor necrosis factor‐α inhibitors;Chen RE;Med (N Y),2021

5. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐TNF therapy impairs both short‐ and long‐term IgG responses after repeated vaccination;Allergy;2024-07-25

2. Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells;Frontiers in Immunology;2024-05-14

3. Update zu COVID-19 und Impfungen gegen respiratorische Erreger bei entzündlich-rheumatischen Erkrankungen;Arthritis und Rheuma;2024-05

4. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses;Journal of Autoimmunity;2024-04

5. Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination;Allergy;2024-03-04